Financing · Sep 15, 2025

Elevance Health, Inc. closed the sale of $3 billion in aggregate principal amount of four series of notes, generating…

ELVElevance Health, Inc.

Elevance Health, Inc. closed the sale of $3 billion in aggregate principal amount of four series of notes, generating approximately $2,972.7 million in net proceeds. The company intends to use the funds to repay $400 million of its 5.350% senior notes due 2025 and $500 million of its 4.900% senior notes due 2026, with the remainder allocated to working capital and general corporate purposes.